Novateor Research Laboratories Ltd

Novateor Research Laboratories Ltd has announced that its Board of Directors will convene on September 3, 2026. The meeting is scheduled to take place at the company's registered office. The primary agenda items include considering and approving matters related to the upcoming Annual General Meeting (AGM) of the company. Additionally, the board will address any other business as approved by the chairman. This announcement is in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Novateor Research Laboratories Ltd has entered into a Marketer and Manufacturer agreement with Smart Laboratories Private Limited. As part of this agreement, Novateor has received a purchase order for 10,000 units of Advance Teeth Whitening Serum, valued at ₹8,40,000 (excluding GST). The order is to be executed within one month. Smart Laboratories has a significant distribution network, which is expected to enhance the market reach of Novateor's oral care products.

Novateor Research Laboratories Limited has launched SmiloShine Herbafresh Toothpaste, a new oral care product formulated with 8 herbs in a 6-gram sachet. This launch is part of the company's forward integration strategy and aims to expand its presence in the FMCG market, targeting the hotel and travel segments. The product will be available in both domestic and international markets, enhancing the company's reach and product portfolio.

Novateor Research Laboratories Ltd approved and adopted the audited financial results for the half year and year ended March 31, 2026, during a Board meeting held on May 30, 2026. The audit report contains a qualified opinion due to non-compliance with several accounting standards, including AS-2, AS-9, AS-15, and AS-17, and issues with GST turnover reconciliation. The auditors, C& H K Shah & Co., highlighted concerns regarding inventory valuation, revenue recognition of unrealized interest income (₹48.39 lakhs), non-provision of gratuity, and lack of segment reporting.

Novateor Research Laboratories Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial results for the half year and year ended March 31, 2026. The trading window will be closed from April 01, 2026, until 48 hours after the results announcement.

Novateor Research Laboratories Ltd has launched SmiloShine Herbafresh Toothpaste, formulated with 8 herbs, on April 30, 2026. This new oral care FMCG product is part of the company's forward integration strategy. It will be available in two variants: a 6-gram pack for the hotel and travel segment, and a 100-gram pack aimed at expanding presence in both Indian and international FMCG markets. The launch signifies the company's move to diversify its product portfolio and reach new customer segments.

Novateor Research Laboratories Ltd has announced the closure of the trading window for all Directors, Designated Persons and their immediate relatives from April 01, 2026. The trading window will be reopened 48 hours after the announcement of the Financial Results for the half year and year ended on March 31, 2026. This decision is in accordance with the Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015.

Novateor Research Laboratories Ltd has launched a new product, Smiloshine Aligner and Denture Cleaner and Whitener Foam, on February 10, 2026. This oral care product is a forward integration step for the company and is expected to cater to both domestic and international markets. The product details are as follows: 1. Name of the Product: Smiloshine Aligner and Denture Cleaner and Whitener Foam, 2. Date of Launch: February 10, 2026, 3. Category of the Product: Oral Care.

Novateor Research Laboratories Ltd has reported its unaudited financial results for the half year ended on 30.09.2025. The company's total income stands at 32,531 with a net profit of 169.26. The company's business activity falls within a single primary segment. The report includes a review by H K Shah & Co. INDIA CHARTERED ACCOUNTANTS, who have issued a qualified conclusion due to non-compliance with AS-2, AS-15, and AS-17. The company has also not identified or reported any segment information as required by AS-17. The report also highlights the treatment of past revaluation of long-lease land.

Novateor Research Laboratories Ltd. held a Board of Directors meeting on November 14, 2025, to approve the unaudited financial results for the half-year ended on September 30, 2025. The company's Standalone financial results, limited review report, and statement on the impact of audit qualification were reviewed. The meeting commenced at 6:30 P.M. and concluded at 9:30 P.M. The company's independent auditor, H K Shah & Co. INDIA CHARTERED ACCOUNTANTS, issued a qualified conclusion report citing deviations from AS-2, AS-15, and AS-17, and emphasizing the treatment of past revaluation of long-lease land.